NorthView Acquisition Corp，一家特殊目的收購公司（SPAC），已發佈其第三季度的 10-Q 報告，詳細説明了重要的財務和運營發展。該公司正在與位於加利福尼亞的生物技術公司 Profusa, Inc.合併，並提供了報告期間的財務表現和戰略業務活動的見解。
財務亮點
<ul>
<li>運營虧損：$(583,581)，反映出與去年相比，形成和運營成本的增加。</li>
<li>淨虧損：$(1,119,910)，主要由於金融工具公允價值的變化和運營費用的增加。</li>
<li>每股基本和稀釋淨虧損，可能贖回的普通股：$(0.19)，表明每股虧損較去年有所增加。</li>
<li>每股基本和稀釋淨虧損，普通股：$(0.19)，與可能贖回的普通股每股虧損一致。</li>
</ul>
業務亮點
<ul>
<li>業務合併進展：NorthView Acquisition Corporation 正在與加利福尼亞公司 Profusa, Inc.完成業務合併。此次合併將導致 Profusa 成為 NorthView 的全資子公司，NorthView 將更名為 Profusa, Inc.</li>
<li>業務合併期限延長：公司已將完成業務合併的期限延長至 2025 年 6 月 22 日，經過股東批准。這一延長為 NorthView 提供了額外的時間來最終確定與 Profusa 的合併。</li>
<li>股東贖回：在報告期間，股東贖回了大量股份，影響了公司的信託賬户餘額。公司已採取措施管理這些贖回，包括與投資者簽訂非贖回協議。</li>
<li>可轉換本票：NorthView 與其贊助商簽訂了一份可轉換本票，該本票已修訂以增加可提取的本金金額。該本票對融資與業務合併相關的交易成本至關重要。</li>
<li>證券購買協議：公司與一位機構投資者簽訂了證券購買協議，以購買高級擔保可轉換本票，這將為業務合併提供額外資金。</li>
<li>納斯達克退市及場外市場報價：由於未在規定時間內完成業務合併，NorthView 的證券已從納斯達克退市。公司的證券現在在場外市場報價。</li>
<li>未來展望：公司專注於在延長的截止日期之前完成與 Profusa 的業務合併。管理層正在積極努力滿足合併所需的條件並獲得必要的批准。</li>
</ul>
SEC 文件：NorthView Acquisition Corp [ NVAC ] - 10-Q -2025 年 6 月 13 日

NVAC

PFSA

NorthView Acquisition Corp 發佈了其第三季度 10-Q 報告，顯示淨虧損為 1,119,910 美元，運營虧損為 583,581 美元。該公司正在與 Profusa, Inc. 合併，並將業務合併的截止日期延長至 2025 年 6 月 22 日。股東贖回對信託賬户產生了影響，NorthView 已修訂了一項可轉換票據以進行融資。其證券在被納斯達克退市後，目前在 OTC 市場報價。該公司旨在在新的截止日期之前完成與 Profusa 的合併

NorthView Acquisition Corp, a special purpose acquisition company (SPAC), has released its Form 10-Q report for the third quarter, detailing significant financial and operational developments. The company, which is in the process of merging with Profusa, Inc., a California-based biotechnology firm, has provided insights into its financial performance and strategic business activities during the reporting period.
<div class="lb-trans">NorthView Acquisition Corp，一家特殊目的收購公司（SPAC），已發佈其第三季度的 10-Q 報告，詳細説明了重要的財務和運營發展。該公司正在與位於加利福尼亞的生物技術公司 Profusa, Inc.合併，並提供了報告期間的財務表現和戰略業務活動的見解。
</div>Financial Highlights
<div class="lb-trans">財務亮點
</div><ul>
<li>Loss from operations: $(583,581), reflecting an increase in formation and operating costs compared to the previous year.</li>
<li>Net Loss: $(1,119,910), primarily driven by changes in fair value of financial instruments and increased operating expenses.</li>
<li>Basic and diluted net loss per share, common stock subject to possible redemption: $(0.19), indicating a higher loss per share compared to the previous year.</li>
<li>Basic and diluted net loss per share, common stock: $(0.19), consistent with the loss per share for common stock subject to possible redemption.</li>
</ul>
<div class="lb-trans"><ul>
<li>運營虧損：$(583,581)，反映出與去年相比，形成和運營成本的增加。</li>
<li>淨虧損：$(1,119,910)，主要由於金融工具公允價值的變化和運營費用的增加。</li>
<li>每股基本和稀釋淨虧損，可能贖回的普通股：$(0.19)，表明每股虧損較去年有所增加。</li>
<li>每股基本和稀釋淨虧損，普通股：$(0.19)，與可能贖回的普通股每股虧損一致。</li>
</ul>
</div>Business Highlights
<div class="lb-trans">業務亮點
</div><ul>
<li>Business Combination Progress: NorthView Acquisition Corporation is in the process of consummating a business combination with Profusa, Inc., a California corporation. This merger will result in Profusa becoming a wholly-owned subsidiary of NorthView, and NorthView will change its name to Profusa, Inc.</li>
<li>Extension of Business Combination Period: The company has extended the period to complete its business combination until June 22, 2025, following stockholder approval. This extension allows NorthView additional time to finalize the merger with Profusa.</li>
<li>Stockholder Redemptions: During the reporting period, stockholders redeemed a significant number of shares, impacting the company's trust account balance. The company has taken steps to manage these redemptions, including entering into a non-redemption agreement with investors.</li>
<li>Convertible Promissory Note: NorthView has a convertible promissory note with its sponsor, which has been amended to increase the principal amount available for drawdown. This note is crucial for financing transaction costs related to the business combination.</li>
<li>Securities Purchase Agreement: The company entered into a securities purchase agreement with an institutional investor for the purchase of senior secured convertible promissory notes, which will provide additional funding for the business combination.</li>
<li>Nasdaq Delisting and OTC Market Quotation: NorthView's securities were delisted from Nasdaq due to not completing a business combination within the required timeframe. The company's securities are now quoted on the OTC Market.</li>
<li>Future Outlook: The company is focused on completing the business combination with Profusa by the extended deadline. The management is actively working on meeting the conditions necessary for the merger and securing the required approvals.</li>
</ul>
<div class="lb-trans"><ul>
<li>業務合併進展：NorthView Acquisition Corporation 正在與加利福尼亞公司 Profusa, Inc.完成業務合併。此次合併將導致 Profusa 成為 NorthView 的全資子公司，NorthView 將更名為 Profusa, Inc.</li>
<li>業務合併期限延長：公司已將完成業務合併的期限延長至 2025 年 6 月 22 日，經過股東批准。這一延長為 NorthView 提供了額外的時間來最終確定與 Profusa 的合併。</li>
<li>股東贖回：在報告期間，股東贖回了大量股份，影響了公司的信託賬户餘額。公司已採取措施管理這些贖回，包括與投資者簽訂非贖回協議。</li>
<li>可轉換本票：NorthView 與其贊助商簽訂了一份可轉換本票，該本票已修訂以增加可提取的本金金額。該本票對融資與業務合併相關的交易成本至關重要。</li>
<li>證券購買協議：公司與一位機構投資者簽訂了證券購買協議，以購買高級擔保可轉換本票，這將為業務合併提供額外資金。</li>
<li>納斯達克退市及場外市場報價：由於未在規定時間內完成業務合併，NorthView 的證券已從納斯達克退市。公司的證券現在在場外市場報價。</li>
<li>未來展望：公司專注於在延長的截止日期之前完成與 Profusa 的業務合併。管理層正在積極努力滿足合併所需的條件並獲得必要的批准。</li>
</ul>
</div>SEC Filing: NorthView Acquisition Corp [ NVAC ] - 10-Q - Jun. 13, 2025
<div class="lb-trans">SEC 文件：NorthView Acquisition Corp [ NVAC ] - 10-Q -2025 年 6 月 13 日
</div>

NorthView Acquisition Corp 的 SEC 10-Q 季度報告